Utah’s business landscape is rich with professionals who have le...Read More
Social Media and Employers: Friends or Enemies?
The Case for HSAs
Time to Show Up
Make a Move
In the Lab
Rent to Own
Back from the Dead
A Breath of Fresh Air
Travel & Tourism
Salt Lake City — CRI Lifetree Salt Lake City Research Center will soon be acquired by PRA, a clinical research organization that operates in more than 80 countries. Lynn R. Webster, chief medical director of CRI Lifetree Salt Lake City Research Center and co-founder of Lifetree Clinical Research (now CRI Lifetree), will remain with the company as the lead scientist for pain and addiction research. Webster is also the current president of the American Academy of Pain Medicine.
“As one of the founders and lead scientists, I am proud of our accomplishments,” Webster said. “It has been rewarding to be a part of the growth of a small company into one of the best in providing early phase trial research.”
CRI Lifetree is a privately held specialized research organization that focuses on the conduct and design of early stage, patient population studies, and is therapeutically focused in Human Abuse Liability (HAL), addiction, pain, psychiatry, neurology, pediatric and infectious disease services.
The company has about 250 full-time employees, is headquartered in Mount Laurel, N.J. with three clinic locations: Marlton, N.J., Philadelphia, Pa., and Salt Lake City. In addition to inpatient and outpatient studies, the company provides early phase research support services such as data management, biostatistics and study report writing.
“CRI Lifetree highly complements PRA’s services and capabilities,” said Colin Shannon, president and CEO, PRA. “Together we are building a leading early Phase CNS platform capable of providing clients with a comprehensive set of specialized clinical services.”